High-intensity exercise can boost dopamine signaling in the brain
Participating in high-intensity exercise can help protect the brain from progressive damage in Parkinson’s disease, a proof-of-concept imaging study…
Marisa holds a Master of Science in cellular and molecular pathology from the University of Pittsburgh, where she studied novel genetic drivers of ovarian cancer. Her areas of expertise include cancer biology, immunology, and genetics, and she has worked as a science writing and communications intern for the Genetics Society of America.
At Bionews we’re committed to providing the most accurate, relevant, and up-to-date reporting for our patient communities. Our goal is to ensure that everyone has access to disease-specific information that is both trustworthy and easy to understand. You can read more about our editorial policy here.
Participating in high-intensity exercise can help protect the brain from progressive damage in Parkinson’s disease, a proof-of-concept imaging study…
By mapping neurological circuits in the brain, an international team of researchers created a model of brain dysfunction that could…
Using machine learning to analyze speech from speakers of different languages could help distinguish between Parkinson’s disease and essential…
Scientists in Denmark have identified the specific nerve signaling pathway that runs from the brain to the spinal cord in…
Apathy is frequently found in people with Parkinson’s disease who also experience problems with impulse control, although the two…
A machine learning tool that analyzes voice recordings collected by telephone can accurately identify people with Parkinson’s disease, scientists…
In a new policy paper, the Movement Disorders Policy Coalition — an advocacy group for people living with movement…
People with Parkinson’s disease who are given deep brain stimulation (DBS) tend to have more stable long-term life quality…
The virus that causes COVID-19 is able to infect dopamine-producing brain cells and trigger a specific pattern of dysfunction that…
Risvodetinib, an experimental therapy that Inhibikase Therapeutics is developing for Parkinson’s disease, was well tolerated both by healthy…
Get regular updates to your inbox.